ESSA Pharma (EPIX) News Today $5.34 -0.08 (-1.48%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 8, 2024 | prnewswire.comESSA Pharma to Present at the JonesHealthcare Seaside SummitJuly 4, 2024 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Shares Cross Below 50 Day Moving Average of $5.83ESSA Pharma (NASDAQ:EPIX) Stock Crosses Below 50-Day Moving Average of $5.83June 19, 2024 | marketbeat.comESSA Pharma Inc. (NASDAQ:EPIX) Sees Large Decline in Short InterestESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a large decline in short interest in May. As of May 31st, there was short interest totalling 843,700 shares, a decline of 7.6% from the May 15th total of 913,100 shares. Based on an average daily trading volume, of 58,700 shares, the days-to-cover ratio is currently 14.4 days.June 7, 2024 | marketbeat.com2,298,662 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by RTW Investments LPRTW Investments LP purchased a new position in ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 2,298,662 shares of the company'May 30, 2024 | prnewswire.comESSA Pharma to Present at the Jefferies Global Healthcare ConferenceMay 24, 2024 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Share Price Passes Below Fifty Day Moving Average of $7.33ESSA Pharma (NASDAQ:EPIX) Stock Price Crosses Below 50 Day Moving Average of $7.33May 21, 2024 | finance.yahoo.comInsider Stock Buying Reaches US$709.0k On ESSA PharmaMay 16, 2024 | marketbeat.comOppenheimer Reiterates "Outperform" Rating for ESSA Pharma (NASDAQ:EPIX)Oppenheimer reissued an "outperform" rating and set a $17.00 target price on shares of ESSA Pharma in a report on Thursday.May 14, 2024 | markets.businessinsider.comBuy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion PotentialMay 14, 2024 | prnewswire.comESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024April 14, 2024 | marketbeat.comShort Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Drops By 13.5%ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 802,800 shares, a drop of 13.5% from the March 15th total of 928,600 shares. Based on an average trading volume of 154,100 shares, the days-to-cover ratio is presently 5.2 days.April 9, 2024 | finance.yahoo.comESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 9, 2024 | prnewswire.comESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceApril 8, 2024 | finance.yahoo.comESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its BusinessApril 7, 2024 | investing.comEssa Pharma COO sells shares worth over $5,500April 5, 2024 | morningstar.comESSA Pharma Inc EPIXMarch 16, 2024 | marketbeat.comESSA Pharma Inc. (NASDAQ:EPIX) Short Interest UpdateESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the recipient of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 979,400 shares, a decline of 13.3% from the February 14th total of 1,130,000 shares. Based on an average daily volume of 154,800 shares, the days-to-cover ratio is presently 6.3 days. Approximately 4.8% of the shares of the stock are sold short.March 10, 2024 | finance.yahoo.comEPIX Jul 2024 7.500 callMarch 10, 2024 | finance.yahoo.comEPIX Jul 2024 12.500 putMarch 7, 2024 | prnewswire.comESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSFebruary 16, 2024 | marketbeat.comShort Interest in ESSA Pharma Inc. (NASDAQ:EPIX) Grows By 5.2%ESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) was the target of a large increase in short interest in January. As of January 31st, there was short interest totalling 1,410,000 shares, an increase of 5.2% from the January 15th total of 1,340,000 shares. Based on an average daily trading volume, of 148,200 shares, the short-interest ratio is currently 9.5 days. Approximately 7.1% of the shares of the company are sold short.February 14, 2024 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPSESSA Pharma (NASDAQ:EPIX - Get Free Report) (TSE:EPI) issued its quarterly earnings results on Tuesday. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.17) by $0.03.February 13, 2024 | benzinga.comESSA Pharma: Q1 Earnings InsightsFebruary 13, 2024 | finance.yahoo.comESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023February 12, 2024 | marketbeat.comESSA Pharma Inc. (NASDAQ:EPIX) Shares Sold by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB decreased its holdings in shares of ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) by 34.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 234,000 shares ofFebruary 8, 2024 | finance.yahoo.comESSA Pharma Inc Executive Peter Virsik Sells 72,782 SharesFebruary 6, 2024 | finance.yahoo.comESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceJanuary 22, 2024 | finance.yahoo.comESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gainsDecember 22, 2023 | marketbeat.comZacks Small Cap Comments on ESSA Pharma Inc.'s Q1 2024 Earnings (NASDAQ:EPIX)ESSA Pharma Inc. (NASDAQ:EPIX - Free Report) (TSE:EPI) - Zacks Small Cap issued their Q1 2024 earnings per share (EPS) estimates for ESSA Pharma in a research note issued on Wednesday, December 20th. Zacks Small Cap analyst D. Bautz expects that the company will earn ($0.15) per share for the quaDecember 20, 2023 | finance.yahoo.comEPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…December 19, 2023 | marketbeat.comESSA Pharma Inc. (NASDAQ:EPIX) CEO David Ross Parkinson Acquires 9,223 SharesESSA Pharma Inc. (NASDAQ:EPIX - Get Free Report) (TSE:EPI) CEO David Ross Parkinson acquired 9,223 shares of ESSA Pharma stock in a transaction dated Thursday, December 14th. The shares were bought at an average price of $2.30 per share, for a total transaction of $21,212.90. Following the transaction, the chief executive officer now owns 65,675 shares of the company's stock, valued at $151,052.50. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.December 14, 2023 | benzinga.comESSA Pharma Stock (NASDAQ:EPIX) Earnings Dates and Earning CallsDecember 13, 2023 | marketbeat.comJefferies Financial Group Raises ESSA Pharma (NASDAQ:EPIX) Price Target to $16.00Jefferies Financial Group upped their price objective on shares of ESSA Pharma from $15.00 to $16.00 and gave the stock a "buy" rating in a research report on Wednesday.December 13, 2023 | marketbeat.comESSA Pharma (NASDAQ:EPIX) Announces Earnings Results, Beats Estimates By $0.10 EPSESSA Pharma (NASDAQ:EPIX - Get Free Report) (TSE:EPI) posted its earnings results on Tuesday. The company reported ($0.12) earnings per share for the quarter, beating analysts' consensus estimates of ($0.22) by $0.10.December 12, 2023 | benzinga.comESSA Pharma Stock (NASDAQ:EPIX) Dividends: History, Yield and DatesDecember 12, 2023 | benzinga.comRecap: ESSA Pharma Q4 EarningsDecember 12, 2023 | finance.yahoo.comESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023December 11, 2023 | finance.yahoo.comBullish ESSA Pharma Insiders Loaded Up On US$1.19m Of StockNovember 24, 2023 | msn.comESSA Pharma director Franklin Berger buys common shares worth ~$133.3KNovember 21, 2023 | finance.yahoo.comESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare ConferenceNovember 8, 2023 | finance.yahoo.comESSA Pharma to Present at the Jefferies London Healthcare ConferenceOctober 31, 2023 | finance.yahoo.comWe Think ESSA Pharma (NASDAQ:EPIX) Can Afford To Drive Business GrowthOctober 30, 2023 | finance.yahoo.comEPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat…October 21, 2023 | finance.yahoo.comESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 CongressAugust 14, 2023 | finance.yahoo.comEPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23…August 14, 2023 | finance.yahoo.comESSA Pharma Inc. (NASDAQ:EPIX) is definitely on the radar of hedge funds investors who own 39% of the companyAugust 8, 2023 | finance.yahoo.comESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023June 6, 2023 | finance.yahoo.comESSA Pharma Appoints Lauren Merendino to its Board of DirectorsJune 1, 2023 | finance.yahoo.comESSA Pharma to Present at 2023 Jefferies Healthcare ConferenceMay 24, 2023 | finance.yahoo.comWe're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here EPIX Media Mentions By Week EPIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EPIX News Sentiment▼1.170.62▲Average Medical News Sentiment EPIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EPIX Articles This Week▼10▲EPIX Articles Average Week Get ESSA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for EPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Cronos Group News Mesoblast News Phibro Animal Health News 4D Molecular Therapeutics News Arbutus Biopharma News Scholar Rock News Zymeworks News Arcturus Therapeutics News IGM Biosciences News KalVista Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EPIX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ESSA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ESSA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.